PEN News & Events

Penumbra announced it has secured CE Mark in Europe for Thunderbolt, further laying the groundwork for launching computer assisted vacuum thrombectomy technology to address acute ischemic stroke globally. The company received U.S. FDA clearance last week.

Penumbra announced it has received U.S. FDA clearance for Thunderbolt, expanding its computer assisted vacuum thrombectomy technology to address acute ischemic stroke. Powered by the Penumbra Engine, Thunderbolt introduces modulated aspiration to Penumbra's neuro thrombectomy portfolio, offering advanced CAVT technology designed to detect, fatigue, and completely ingest clot at the site of the occlusion.